Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease
Michael McDermott(Unknown), Serge Gauthier(Texas Instruments (France)), William C. Koller(Stanford University), Stanley Fahn(Columbia University Irving Medical Center), Christopher G. Goetz(Rush University Medical Center), Ira Shoulson(Baylor College of Medicine), J. Carter, Lawrence I. Golbe(Rutgers, The State University of New Jersey), Joseph Jankovic(Baylor College of Medicine), William J. Weiner(University of Maryland, Baltimore), Caroline M. Tanner(University of California, San Francisco), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Anthony E. Lang(University of Toronto), M. B. Stern(Duke University)
Cited by 60
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
A polymorphic DNA marker genetically linked to Huntington's disease
|Nature|1983|2.3k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k